The iconic status of Viagra, and the parent firm copyright, presents a complex question for investors . While revenues initially soared , the looming patent lapse and growing generic rivalry represent a https://heidinriw665999.bloggerchest.com/41639456/the-blue-pill-and-pharma-a-uncertain-investment